Copyright
©The Author(s) 2021.
World J Clin Oncol. Aug 24, 2021; 12(8): 656-663
Published online Aug 24, 2021. doi: 10.5306/wjco.v12.i8.656
Published online Aug 24, 2021. doi: 10.5306/wjco.v12.i8.656
Pyrosequencing (all patients) | NGS(all patients) | Lung cancer | cfDNA | ALK (IHC) | ROS-1 (IHC) | |
2016 | 128 | 1 | 39 | 5 | 8 | 0 |
2017 | 82 | 29 | 38 | 10 | 6 | 0 |
2018 | 0 | 125 | 49 | 28 | 51 | 0 |
2019 | 0 | 93 | 33 | 12 | 34 | 16 |
- Citation: Saarenheimo J, Andersen H, Eigeliene N, Jekunen AP. Current challenges in applying gene-driven therapies in clinical lung cancer practice. World J Clin Oncol 2021; 12(8): 656-663
- URL: https://www.wjgnet.com/2218-4333/full/v12/i8/656.htm
- DOI: https://dx.doi.org/10.5306/wjco.v12.i8.656